Table 1.
Mean percentages (±sems) of FOS double-labeled GnRH1 and Kisspeptin-10 (Kp10) neurons analyzed per animal group after different treatments in wild-type and knockout subjects
| Analysis treatment | Female Afp+/+
|
Female Afp−/−
|
Male Afp+/+
|
Male Afp−/−
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FOS/Kp10 | FOS/GnRH1 | No. | FOS/Kp10 | FOS/GnRH1 | No. | FOS/Kp10 | FOS/GnRH1 | No. | FOS/Kp10 | FOS/GnRH1 | No. | |
| Control | 0 | 6.3 ± 2.2 | 11 | 0 | 0.8 ± 0.4 | 4 | 1.81 ± 3.6 | 0.2 ± 0.1 | 5 | |||
| EB | 37.5 ± 7.9 | 31.8 ± 9.5 | 7 | 1.8 ± 1.81 | 0 | 5 | 0 | 0 | 3 | 0 | 0 | 4 |
| EB + P | 41.6 ± 12.5 | 47.1 ± 4.8 | 8 | 2.6 ± 5.02 | 0 | 8 | 0 | 0.1 ± 0.1 | 6 | 0 | 0.1 ± 0.6 | 6 |
Analysis refers to sex, genotype, and immunochemical analysis (FOS/Kp10 and FOS/GnRH1). Treatment refers to: Control, EB, and EB+P.